November is National Diabetes Awareness Month, an initiative led by the American Diabetes Association to educate people on the risks and treatment options for type 2 diabetes. Diabetes is now one of the leading causes of disability and death in the United States, and the epidemic continues to grow.
More than 30 million people are living with type 2 diabetes in the U.S. alone (that’s 10% of the population!), and another 86 million adults are living with prediabetes. The disease contributes to more than 250,000 deaths per year, while costing the nation more than $300B annually.
The statistics are daunting, but there is good news! Highwire client Virta Health is on a mission to reverse type 2 diabetes in 100 million people by 2025, and they are succeeding! Virta Health has developed the first treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.
Among enrolled patients in the company’s clinical trial at one year, 60% achieved diabetes reversal in as little as 10 weeks and 94% of patients on insulin either reduced their usage or eliminated it altogether.
This month, Virta released exciting data from their pilot with the U.S. Department of Veterans Affairs (VA). Diabetes prevalence is even higher among US veterans than the average adult population, affecting nearly 25% of VA patients. In the pilot program, 84% of veteran patients on the Virta Treatment for 90 days achieved glycemic outcomes below the diabetes threshold or at least a one-point drop in HbA1c (a measure of blood sugar).
Results of the Virta Treatment extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with sustained improvements in blood pressure, inflammation, liver function, and BMI. These outcomes are bringing life-changing freedom from the debilitating physical and emotional effects of diabetes to thousands of people. Virta’s patient stories are proof.
We’re proud to support and amplify Virta’s mission to reverse diabetes not just in November, but throughout the year.